- Home
- ELWT vs ATRA Comparison
ELWT vs ATRA Comparison
Compare ELWT & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELWT | ATRA |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4M | 38.9M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | ELWT | ATRA |
|---|---|---|
| Price | $6.89 | $4.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $6.00 |
| AVG Volume (30 Days) | 54.6K | ★ 292.7K |
| Earning Date | 05-15-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | N/A | ★ 2.57 |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | $167.76 | N/A |
| Revenue Next Year | $22.42 | N/A |
| P/E Ratio | ★ N/A | $1.94 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.11 | $3.92 |
| 52 Week High | $8.25 | $19.15 |
Technical Indicators
Market Signals| Indicator | ELWT | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 57.34 | 43.84 |
| Support Level | $6.11 | $4.27 |
| Resistance Level | $7.05 | $5.80 |
| Average True Range (ATR) | 0.71 | 0.68 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 54.56 | 11.15 |
Price Performance
Historical ComparisonAbout ELWT Elauwit Connection Inc.
Elauwit Connection Inc is a customer-centric service provider of broadband Internet networks for the multifamily and student housing property sectors across the United States. The company generates revenue from the following sources: network design and installation and internet network services. It provides service offering wholesale to REITs, property ownership groups, and property management companies, engaged in its target real estate sectors.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).